Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Acacia Pharma Group    ACPH   GB00BYWF9Y76

ACACIA PHARMA GROUP (ACPH)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 12/14 05:35:07 pm
1.56 EUR   -9.10%
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
12/10/2018 12/11/2018 12/12/2018 12/13/2018 12/14/2018 Date
1.67(c) 1.67(c) 1.9494(c) 1.7162(c) 1.56 Last
152 491 36 249 327 359 143 264 168 320 Volume
-7.11% 0.00% +16.73% -11.96% -9.10% Change
More quotes
Financials (GBP)
Sales 2018 -
EBIT 2018 -18,4 M
Net income 2018 -17,5 M
Debt 2018 -
Yield 2018 -
Sales 2019 2,50 M
EBIT 2019 -45,1 M
Net income 2019 -43,2 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 0
Capi. / Sales2019 33,0x
Capitalization 82,4 M
More Financials
Company
Acacia Pharma specializes in the research and development of supportive care medicines. The products are intended to support the side effects of anti-cancer treatments (including nausea and vomiting drugs). At the end of January 2018, the group had a portfolio of 2 products, including APD403 in... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on ACACIA PHARMA GROUP
08:01aTR-1 : Standard form for notification of major holdings
GL
12/13ACACIA PHARMA : Positive Clinical Results for APD403 in CINV Published in Suppor..
AQ
12/12ACACIA PHARMA GROUP PLC : Acacia Pharma announces positive clinical results for ..
GL
12/10ACACIA PHARMA : New BARHEMSYS PDUFA date confirmed for 5 May 2019
AQ
12/07ACACIA PHARMA GROUP PLC : Acacia pharma announces barhemsys(tm) pdufa date of 5 ..
GL
11/22ACACIA PHARMA : Announces Positive Barhemsys Rescue Treatment Data Published In ..
AQ
11/21ACACIA PHARMA : Announces positive barhemsys(tm) rescue treatment data published..
AQ
11/21ACACIA PHARMA : Acacia pharma announces positive barhemsys(tm) rescue treatment ..
GL
11/08ACACIA PHARMA GROUP PLC - TR-1 : Standard form for notification of major holding..
GL
11/06ACACIA PHARMA : Group plc - PDMR DEALING/EXERCISE OF SHARE OPTIONS
GL
More news
Sector news : Pharmaceuticals - NEC
01:42pMERCK AND : to Buy Animal Health Tech Business for $2.37 Billion
DJ
01:34pELI LILLY AND : Expands Collaboration With Evidation Health
DJ
01:29pMERCK AND : bolsters animal health unit with $2.4 billion Antelliq purchase
RE
11:26aThyssenkrupp fills key management posts after year of turmoil
RE
11:26aThyssenkrupp fills key management posts after year of turmoil
RE
More sector news : Pharmaceuticals - NEC
Chart ACACIA PHARMA GROUP
Duration : Period :
Acacia Pharma Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ACACIA PHARMA GROUP
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 3,81  GBP
Spread / Average Target 147%
EPS Revisions
Managers
NameTitle
Gilbert Julian Clive Chief Executive Officer & Director
Scott A. Byrd Non-Executive Director
Patrick Volkert Vink Non-Executive Chairman
Christine Helen Soden Chief Financial Officer, Secretary & Director
Gabriel Fox Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ACACIA PHARMA GROUP0.00%104
JOHNSON & JOHNSON5.81%396 504
PFIZER21.92%258 506
NOVARTIS6.21%224 691
ROCHE HOLDING LTD.3.12%220 215
MERCK AND COMPANY40.41%205 456